A CHINESE herb named
tripterygium wilfordii Hook F
(TwHF) has been compared for
monotherapy and combined
therapy with methotrexate (MTX)
in a multicentre, open-label,
randomised controlled trial treating
active rheumatoid arthritis (RA)
and published in the Annals of
Rheumatic Diseases.
The authors concluded that TwHF
was found to be non-inferior to
MTX in monotherapy and MTX
+ TwHF was superior to MTX in
controlling disease activity.
CLICK HERE to read the paper.The above article was sent to subscribers in Pharmacy Daily's issue from 29 Apr 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 29 Apr 14
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.